Sacubitril/valsartan alleviates myocardial infarction-induced inflammation in mice by promoting M2 macrophage polarisation via regulation of PI3K/Akt pathway

Nan Jin Ying Qiu Kuanxin Zhang Yulin Fang Shifang Qu Lu Zhu Han Li Bin Nie a Department of Geriatrics,The Sixth Hospital of Wuhan,Affiliated Hospital of Jianghan University,Wuhan,Chinab Department of General practice,Affiliated Hospital of Jianghan University,Wuhan,China
DOI: https://doi.org/10.1080/00015385.2024.2400401
IF: 1.738
2024-09-11
Acta Cardiologica
Abstract:Background Macrophage polarisation-mediated inflammation plays a critical role in ventricular remodelling after myocardial infarction (MI). Sacubitril/Valsartan (Sac/Val) is an angiotensin receptor-neprilysin inhibitor that has shown beneficial effects on MI and heart failure. This study aims to further explore the mechanisms by which Sac/Val exerts its protective effects against MI.
cardiac & cardiovascular systems
What problem does this paper attempt to address?